Drugs Pricing in France - Balancing Innovation vs Cost Containment: The New Agreement between the Government and the Pharma industry
On January 11th 2016, the Comité Economique des Produits de Santé (CEPS - Economic Committee for Health Products) signed on the behalf of the French Government a new agreement, the Accord cadre, with Les entreprises du médicament (LEEM - pharmaceutical companies association) on how to set reimbursed drugs prices for the next 3 years. The CEPS is the body that negotiates drug prices with manufacturers.While details are lacking, the response of pharmaceutical companies is positive. Patrick Errard,...
To continue reading this story
Please note: That all fields marked with an asterisk (*) are required.